Immortalized Human Mammary Epithelial Cells (HMEC 2.6)

Cat.No.: CSC-I9116L

Species: Homo sapiens

Source: Mammary Tissue

Morphology: Polygonal

Culture Properties: Adherent

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-I9116L
Description
Immortalized Human Mammary Epithelial Cells (HMEC 2.6) is an immortalized breast epithelial cell line which are not tumorigenic and do not show no anchorage-independent growth. There is a normal distribution of cells in G1, S, and G2/M phase and they express normal breast epithelial markers ( E-cadherin, CK7/18, and CK5/14). The cells retain primary characteristics and are valuable for research relating to mammary epithelial biology.
Species
Homo sapiens
Source
Mammary Tissue
Culture Properties
Adherent
Morphology
Polygonal
Immortalization Method
Serial passaging and transduction with LXSN-based retroviruses carrying hTERT gene
Markers
E-cadherin, EGFR, MIB1, CD10, CK5/14, P63, and CK7/18
Application
For Research Use Only
Storage
Directly and immediately transfer cells from dry ice to liquid nitrogen upon receiving and keep the cells in liquid nitrogen until cell culture needed for experiments.

Note: Never can cells be kept at -20 °C.
Shipping
Dry Ice.
Recommended Products
CSC-C4038X Human Mammary Epithelial Cells (HMEpC)
CIK-HT013 HT® Lenti-hTERT Immortalization Kit
CIK-HT003 HT® Lenti-SV40T Immortalization Kit
Quality Control
1) Cell markers were probed via immunohistochemical analysis;
2) Soft agar assay preformed to determine anchorage-independence.
BioSafety Level
II
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Immortalized Human Mammary Epithelial Cells 2.6 (HMEC 2.6) are epithelial cells isolated from normal mammary tissue. They have been genetically altered in a well-defined manner to allow for continuous growth in culture. These cells were immortalized with the intention of providing scientists with a mammary epithelial cell line that maintained characteristics of epithelial cells while allowing for greater longevity in culture than primary mammary epithelial cells. HMEC 2.6 cells characteristically show epithelial morphology and expression of epithelial markers such as cytokeratins and cell-cell adhesion proteins.

Due to their epithelial origin, HMEC 2.6 cells function similarly to normal breast epithelial cells. They can be used to study normal mammary gland biology including proliferation, differentiation, and epithelial cell interactions. When provided with the correct conditions, these cells will demonstrate organization that is characteristic of epithelial tissues. HMEC 2.6 cells also respond to growth factors and hormones in a manner similar to normal mammary epithelial cells. As these cells are derived from normal mammary tissue, they are often used as a control to compare the biology between normal breast cells and breast cancer cells.

Reconfirmation of RAB25 Downregulation in HMEC Lines

RAB25 loss correlates with H-RAS mutations in triple-negative breast cancer (TNBC), but mechanisms driving tumor progression remain unclear. Joshi et al. wanted to further explore the cooperative effect of loss of RAB25 with activating mutations in H-RAS in HMECs. Previous studies have shown that loss of RAB25 acts as a tumor suppressor gene. However, it was unclear whether loss of RAB25 only cooperated with H-RAS61L specifically or with other oncogenes as well. To study this, immortal human mammary epithelial cell lines were created which had loss of RAB25. Cells named HMEC 2.6 and HMEC 5.6 were confirmed to have knockdown of RAB25 via shRNA. Quantitative PCR and western blot analysis were performed showing loss of RAB25 on both the mRNA and protein level when compared to parental controls (Fig. 1 and 2).

Reconfirmation of RAB25 downregulation in HMEC lines.

Fig. 1. Reconfirmation of RAB25 downregulation in HMEC lines (Joshi P, Ayyagari V, et al., 2024).

Reconfirmation of RAB25 downregulation in HMEC lines.

Fig. 2. Reconfirmation of RAB25 downregulation in HMEC lines (Joshi P, Ayyagari V, et al., 2024).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products